Doxorubicin

Red

Brand Name(s):Caelyx, Myocet

Indication:Ovarian Cancer- recurrent

Acute leukaemias, Hodgkins & non-Hodgkins lymphomas. Progressive Multiple Myeloma.For AIDS-related Kaposi’s sarcoma in patients with low CD4 count and extensive mucocutaneous or visceral disease, Advanced ovarian cancer when platinum-based chemotherapy has failed, Monotherapy for metastatic breast cancer with increased cardiac risk.

Rationale:1,2,3

Considered:Dec-07

Review Date:Aug-26

Comments:
NICE TA389 1.2Pegylated liposomal doxorubicin hydrochloride (PLDH) as monotherapy is recommended within its marketing authorisation as an option for treating recurrent ovarian cancer. …………………………NICE NG52
Non-Hodgkin’s lymphoma: diagnosis and management
July 2016